The endocannabinoid signalling system: Biochemical aspects

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 2 SPEC. ISS., 2005, Pages 224-238

  Bisogno, Tiziana ^a   Ligresti, Alessia ^a   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

2 Arachidonoylglycerol; Anandamide; Anandamide transporter; Cannabinoid receptors; Fatty acid amide hydrolase

Indexed keywords

1,6 HEXAMETHYLENEDICARBAMIC ACID BIS(CYCLOHEXANONE OXIME) ESTER; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID AMIDASE; N (3 FURYLMETHYL)ARACHIDONAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N ARACHIDONOYLDOPAMINE; NOLADIN; O 1981; RIMONABANT; UCN 707; UNCLASSIFIED DRUG; VIRHODAMINE;

ANALGESIC ACTIVITY; BIOCHEMISTRY; BIOSYNTHESIS; CONFERENCE PAPER; HUMAN; HYDROLYSIS; IC 50; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 20444460345     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.01.027     Document Type: Conference Paper

References (154)

1. J. Ahluwalia, L. Urban, S. Bevan, and I. Nagy Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro Eur J Neurosci 17 2003 2611 2618
2. D. Baker, G. Pryce, J.L. Croxford, P. Brown, R.G. Pertwee, and A. Makriyannis Endocannabinoids control spasticity in a multiple sclerosis model FASEB J 15 2001 300 302
3. B.S. Basavarajappa, M. Saito, T.B. Cooper, and B.L. Hungund Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons Biochim Biophys Acta 1535 2000 78 86
4. B.S. Basavarajappa, M. Saito, T.B. Cooper, and B.L. Hungund Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons Eur J Pharmacol 466 2003 73 83
5. M. Begg, F.M. Mo, L. Offertaler, S. Batkai, P. Pacher, and R.K. Razdan G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current J Biol Chem 278 2003 46188 46194
6. M. Beltramo, N. Stella, A. Calignano, S.Y. Lin, A. Makriyannis, and D. Piomelli Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1997 1094 1097
7. S. Ben-Shabat, E. Fride, T. Sheskin, T. Tamiri, M.H. Rhee, and Z. Vogel An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Eur J Pharmacol 353 1998 23 31
8. E.V. Berdyshev, P.C. Schmid, R.J. Krebsbach, and H.H. Schmid Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells FASEB J 15 2001 2171 2178
9. T. Bisogno, N. Sepe, D. Melck, S. Maurelli, L. De Petrocellis, and Di Marzo Biosynthesis, release and degradation of THE novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells Biochem J 322 1997 671 677
10. T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis, and V. Di Marzo Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes J Biol Chem 272 1997 3315 3323
11. T. Bisogno, D. Melck, L. De Petrocellis, M.Y.u. Bobrov, N.M. Gretskaya, and V.V. Bezuglov Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase Biochem Biophys Res Commun 248 1998 515 522
12. T. Bisogno, D. Melck, L. De Petrocellis, and V. Di Marzo Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin J Neurochem 72 1999 2113 2119
13. T. Bisogno, D. Melck, M.Y.u. Brobrov, N.M. Gretskaya, V.V. Besuglov, and L. De Petrocellis N-acyl-dopamines: novel synthetic cb(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo Biochem J 351 2000 817 824
14. T. Bisogno, F. Howell, G. Williams, A. Minassi, M.G. Cascio, and A. Ligresti Cloning of the first sn1-dag lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain J Cell Biol 163 2003 463 468
15. T. Bisogno, L. De Petrocellis, and V. Di Marzo Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications Curr Pharm Des 8 2002 533 47
16. L.M. Bornheim, K.Y. Kim, B. Chen, and M.A. Correia The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism Biochem Biophys Res Commun 197 1993 740 746
17. L.M. Bornheim, K.Y. Kim, B. Chen, and M.A. Correia Microsomal cytochrome P450-mediated liver and brain anandamide metabolism Biochem Pharmacol 50 1995 677 686
18. M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, and M. Rinaldi-Carmona Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 1995 637 641
19. M.H. Bracey, M.A. Hanson, K.R. Masuda, R.C. Stevens, and B.F. Cravatt Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling Science 298 2002 1793 1796
20. C.S. Breivogel, G. Griffin, V. Di Marzo, and B.R. Martin Evidence for a new G protein-coupled cannabinoid receptor in mouse brain Mol Pharmacol 60 2001 155 163
21. J.W. Brooks, G. Pryce, T. Bisogno, S.I. Jaggar, D.J. Hankey, and P. Brown Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid vr1 receptor and cannabinoid CB(1)/CB(2) receptors Eur J Pharmacol 439 2002 83 92
22. H. Cadas, E. di Tomaso, and D. Pomelli Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain J Neurosci 17 1997 1226 1242
23. E.J. Carrier, C.S. Kearn, A.J. Barkmeier, N.M. Breese, W. Yang, and K. Nithipatikom Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a Cb2 receptor-dependent mechanism Mol Pharmacol 65 2004 999 1007
24. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
25. J. Chemin, A. Monteil, E. Perez-Reyes, J. Nargeot, and P. Lory Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide EMBO J 20 2001 7033 7040
26. V. Chevaleyre, and P.E. Castillo Heterosynaptic LTD of hippocampal gabaergic synapses: a novel role of endocannabinoids in regulating excitability Neuron 38 2003 461 472
27. S.J. Craib, H.C. Ellington, R.G. Pertwee, and R.A. Ross A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus Br J Pharmacol 134 2001 30 37
28. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
29. B.F. Cravatt, and A.H. Lichtman Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system Curr Opin Chem Biol 7 2002 469 475
30. E. de Lago, J. Fernandez-Ruiz, S. Ortega-Gutierrez, A. Viso, M.L. Lopez-Rodriguez, and J.A. Ramos UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide Eur J Pharmacol 449 2002 99 103
31. E. de Lago, A. Ligresti, G. Ortar, E. Morera, A. Cabranes, and G. Pryce In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake Eur J Pharmacol 484 2004 249 257
32. L. De Petrocellis, D. Melck, N. Ueda, S. Maurelli, Y. Kurahashi, and S. Yamamoto Novel inhibitors Of brain, neuronal, and basophilic anandamide amidohydrolase Biochem Biophys Res Commun 231 1997 82 88
33. L. De Petrocellis, T. Bisogno, J.B. Davis, R.G. Pertwee, and V. Di Marzo Overlap between the ligand recognition properties of the anandamide transporter and the vr1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity FEBS Lett 483 2000 52 56
34. L. De Petrocellis, T. Bisogno, M. Maccarrone, J.B. Davis, A. Finazzi-Agro, and V. Di Marzo The activity of anandamide at vanilloid vr1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism J Biol Chem 276 2001 12856 12863
35. L. De Petrocellis, J.B. Davis, and V. Di Marzo Palmitoylethanolamide enhances anandamide stimulation of human vanilloid vr1 receptors FEBS Lett 506 2001 253 256
36. L. De Petrocellis, S. Harrison, T. Bisogno, M. Tognetto, I. Brandi, and G.D. Smith The vanilloid receptor (vr1)-mediated effects of anandamide are potently enhanced by the camp-dependent protein kinase J Neurochem 77 2001 1660 1663
37. D.G. Deutsch, R. Omeir, G. Arreaza, D. Salehani, G.D. Prestwich, and Z. Huang Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase Biochem Pharmacol 53 1997 255 260
38. D.G. Deutsch, S. Lin, W.A. Hill, K.L. Morse, D. Salehani, and G. Arreaza Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor Biochem Biophys Res Commun 231 1997 217 221
39. D.G. Deutsch, S.T. Glaser, J.M. Howell, J.S. Kunz, R.A. Puffenbarger, and C.J. Hillard The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase J Biol Chem 276 2001 6967 6973
40. D.G. Deutsch, N. Ueda, and S. Yamamoto The fatty acid amide hydrolase (FAAH) Prostaglandins Leukot Essent Fatty Acids 66 2002 201 210
41. W.A. Devane, F.A. Dysarz, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1998 605 613
42. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949
43. V. Di Marzo, and D.G. Deutsch Biochemistry of the endogenous ligands of cannabinoid receptors Neurobiol Dis 5 1998 386 404
44. V. Di Marzo, and A. Fontana Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone' Prostaglandins Leukot Essent Fatty Acids 53 1995 1 11
45. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, and J.C. Schwartz Formation and inactivation of endogenous cannabinoid anandamide in central neurons Nature 372 1994 686 691
46. V. Di Marzo, L. De Petrocellis, T. Sugiura, and K. Waku Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells Biochem Biophys Res Commun 227 1996 281 288
47. V. Di Marzo, T. Bisogno, L. De Petrocellis, D. Melck, P. Orlando, and J.A. Wagner Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages Eur J Biochem 264 1999 258 267
48. V. Di Marzo, C.S. Breivogel, Q. Tao, D.T. Bridgen, R.K. Razdan, and A.M. Zimmer Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain J Neurochem 75 2000 2434 2444
49. V. Di Marzo, T. Bisogno, L. De Petrocellis, I. Brandi, R.G. Jefferson, and R.L. Winckler Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands Biochem Biophys Res Commun 281 2001 444 451
50. V. Di Marzo, G. Griffin, L. De Petrocellis, I. Brandi, T. Bisogno, and W. Williams A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid J Pharmacol Exp Ther 300 2002 984 991
51. V. Di Marzo, T. Bisogno, and L. De Petrocellis Anandamide: some like it hot Trends Pharmacol Sci 22 2002 346 349
52. V. Di Marzo, L. De Petrocellis, F. Fezza, A. Ligresti, and T. Bisogno Anandamide receptors Prostaglandins Leukot Essent Fatty Acids 66 2002 377 391
53. T.P. Dinh, D. Carpenter, F.M. Lesile, T.F. Freund, I. Katona, and S.L. Sensi Brain monoglyceride lipase participating in endocannabinoid inactivation Proc Natl Acad Sci U S A 99 2002 10819 10824
54. W.S. Edgemond, C.J. Hillard, J.R. Falck, C.S. Kearn, and W.B. Campbell Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation Mol Pharmacol 54 1998 180 188
55. D. Fegley, S. Kathuria, R. Mercier, C. Li, A. Goutopoulos, and A. Makriyannis Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172 Proc Natl Acad Sci U S A 101 2004 8756 8761
56. F. Fezza, T. Bisogno, A. Minassi, G. Appendino, R. Mechoulam, and V. Di Marzo Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues FEBS Lett 513 2002 294 298
57. C.J. Fowler, G. Tiger, A. Ligresti, M.L. Lopez-Rodriguez, and V. Di Marzo Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-a difficult issue to handle Eur J Pharmacol 492 2004 1 11
58. Y. Gaoni, and R. Mechoulam The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish J Am Chem Soc 93 1971 217 224
59. S.T. Glaser, N.A. Abumrad, F. Fatade, M. Kaczocha, K.M. Studholme, and D.G. Deutsch Evidence against the presence of an anandamide transporter Proc Natl Acad Sci U S A 100 2003 4269 4274
60. T. Gomez del Pulgar, G. Velasco, and M. Guzman The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt Biochem J 347 2000 369 373
61. S.K. Goparaju, N. Ueda, K. Taniguchi, and S. Yamamoto Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors Biochem Pharmacol 57 1999 417 423
62. P. Gubellini, B. Picconi, M. Bari, N. Battista, P. Calabresi, and D. Centone Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission J Neurosci 22 2002 6900 6907
63. A.I. Gulyas, B.F. Cravatt, M.H. Bracey, T.P. Dinh, D. Piomelli, and F. Boscia Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala Eur J Neurosci 20 2004 441 458
64. N. Hajos, C. Ledent, and T.F. Freund Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus Neuroscience 106 2001 1 4
65. N. Hajos, S. Kathuria, T. Dinh, D. Piomelli, and T.F. Freund Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404 Eur J Neurosci 19 2004 2991 2996
66. H.S. Hansen, L. Lauritzen, B. Moesgaard, A.M. Strand, and H.H. Hansen Formation of N-acyl-phosphatidylethanolamines and N-acetylethanolamines: proposed role in neurotoxicity Biochem Pharmacol 55 1998 719 725
67. L. Hanus, S. ABU-Lafi, E. Fride, A. Breuer, Z. Vogel, and D.E. Shalev 2-Arachidonyl glyceryl ether, an endogenous agonist of THE cannabinoid CB1 receptor Proc Natl Acad Sci U S A 98 2001 3662 3665
68. C.J. Hillard, and A. Jarrahian Cellular accumulation of anandamide: consensus and controversy Br J Pharmacol 140 2003 802 808
69. C.J. Hillard, W.S. Edgemond, A. Jarrahian, and W.B. Campbell Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion J Neurochem 69 1997 631 638
70. S.Y. Ho, L. Delgado, and J. Storch Monoacylglycerol metabolism in human intestinal caco-2 cells: evidence for metabolic compartmentation and hydrolysis J Biol Chem 277 2002 1816 1823
71. S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, and F. Fezza An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid vr1 receptors Proc Natl Acad Sci U S A 99 2002 8400 8405
72. M. Karlsson, K. Reue, Y.R. Xia, A.J. Lusis, D. Langin, and H. Tornqvist Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene Gene 272 2001 11 18
73. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, and A. Tontini Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 2003 76 81
74. S. Kondo, H. Kondo, S. Nakane, T. Kodaka, A. Tokumura, and K. Waku 2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through CA2+-dependent and -independent mechanisms FEBS Lett 429 1998 152 156
75. K.R. Kozak, and L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot Essent Fatty Acids 66 2002 211 220
76. K.R. Kozak, R.A. Gupta, J.S. Moody, C. Ji, W.E. Boeglin, and R.N. DuBois 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist J Biol Chem 277 2002 23278 23286
77. Z. Jarai, J.A. Wagner, K. Varga, K.D. Lake, D.R. Compton, and B.R. Martin Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc Natl Acad Sci U S A 96 1999 14136 14141
78. A. Jarrahian, S. Manna, W.S. Edgemond, W.B. Campbell, and C.J. Hillard Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter J Neurochem 74 2000 2597 2606
79. A.A. Izzo, F. Capasso, A. Costagliela, T. Bisogno, G. Morsicano, and A. Ligresti An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice Gastroenterology 125 2003 765 774
80. A.H. Lichtman, E.G. Hawkins, G. Griffin, and B.F. Cravatt Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo J Pharmacol Exp Ther 302 2002 73 79
81. A.H. Lichtman, D. Leung, C. Shelton, A. Saghatelian, C. Hardouin, and D. Boger Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity J Pharmacol Exp Ther 311 2004 441 448
82. A. Ligresti, E. Morera, M. van der Stelt, K. Monory, B. Lutz, and G. Ortar Further evidence for the existence of a specific process for the membrane transport of anandamide Biochem J 380 2004 265 272
83. Q. Liu, T. Tonai, and N. Ueda Activation of N-acylethanolamine-releasing phospholipase D by polyamines Chem Phys Lipids 115 2002 77 84
84. J. Liu, S. Batkai, P. Pacher, J. Harvey-White, J.A. Wagner, and B.F. Cravatt Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-KAPPAB independently of platelet-activating factor J Biol Chem 278 2003 45034 45039
85. M.L. Lopez-Rodriguez, A. Viso, S. Ortega-Gutierrez, I. Lastres-Becker, S. Gonzalez, and J. Fernandez-Ruiz Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors J Med Chem 44 2001 4505 4508
86. M.L. Lopez-Rodriguez, A. Viso, S. Ortega-Gutierrez, C.J. Fowler, G. Tiger, and E. de Lago Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase J Med Chem 46 2003 1512 1522
87. M.L. Lopez-Rodriguez, A. Viso, S. Ortega-Gutierrez, C.J. Fowler, G. Tiger, and E. de Lago Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors Eur J Med Chem 38 2003 403 412
88. M. Maccarrone, M. van der Stelt, A. Rossi, G.A. Veldink, J.F. Vliegenthart, and A.F. Agro Anandamide hydrolysis by human cells in culture and brain J Biol Chem 273 1998 32332 32339
89. M. Maccarrone, L. Fiorucci, F. Erba, M. Bari, A. Finazzi-Agro, and F. Ascoli Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors FEBS Lett 468 2000 176 180
90. M. Maccarrone, M. Bari, T. Lorenzon, T. Bisogno, V. Di Marzo, and A. Finazzi-Agro Anandamide uptake by human endothelial cells and its regulation by nitric oxide J Biol Chem 275 2000 13484 13492
91. M. Maccarrone, M. Di Rienzo, A. Finazzi-Agro, and A. Rossi Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3 J Biol Chem 278 2003 13318 13324
92. M. Maccarrone, M. Bari, M. Di Rienzo, A. Finazzi-Agro, and A. Rossi Progesterone activates fatty acid amide hydrolase (FAAH) promoter in human T lymphocytes through the transcription factor Ikaros. Evidence for a synergistic effect of leptin J Biol Chem 278 2003 32726 32732
93. K. Mackie, and B. Hille Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells Proc Natl Acad Sci U S A 89 1992 3825 3829
94. K. Mackie, Y. Lai, R. Westenbroek, and R. Mitchell Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor J Neurosci 15 1995 6552 6561
95. F. Maingret, A.J. Patel, M. Lazdunski, and E. Honore The endocannabinoid anandamide is a direct and selective blocker of the background K(+) channel TASK-1 EMBO J 20 2001 47 54
96. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, and A. Cannich CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 2003 84 88
97. B.R. Martin, I. Beletskaya, G. Patrick, R. Jefferson, R. Winckler, and D.G. Deutsch Cannabinoid properties of methylfluorophosphonate analogs J Pharmacol Exp Ther 294 2000 1209 1218
98. N. Mascolo, A.A. Izzo, A. Ligresti, A. Costagliela, L. Pinto, and M.G. Cascio The endocannabinoid system and the molecular basis of paralytic ileus in mice FASEB J 16 2002 1973 1975
99. I. Matias, J. Chen, L. De Petrocellis, T. Bisogno, A. Ligresti, and F. Fezza Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism J Pharmacol Exp Ther 309 2004 745 757
100. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
101. S.D. McAllister, G. Griffin, L.S. Satin, and M.E. Abood Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system J Pharmacol Exp Ther 291 1999 618 626
102. M.J. McFarland, A.C. Porter, F.R. Rakhshan, D.S. Rawat, R.A. Gibbs, and E.L. Barker A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide J Biol Chem 279 2004 41991 41997
103. D.C. McVey, P.C. Schmid, H.H. Schmid, and S.R. Vigna Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1) J Pharmacol Exp Ther 304 2003 713 722
104. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
105. R. Mechoulam, E. Fride, S. Ben-Shabat, U. Meiri, and M. Horowitz Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid Eur J Pharmacol 362 1998 R1 R3
106. F.M. Mo, L. Offertaler, and G. Kunos Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1 Eur J Pharmacol 489 2004 21 27
107. E. Molina-Holgado, J.M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, and J. Borrell Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 Kinase/Akt Signaling J Neurosci 22 2002 9742 9753
108. K. Monory, E.T. Tzavara, J. Lexime, C. Ledent, M. Parmentier, and A. Borsodi Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice Biochem Biophys Res Commun 292 2002 231 235
109. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
110. C.S. Nirodi, B.C. Crews, K.R. Kozak, J.D. Morrow, and L.J. Marnett The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in Raw264.7 cells Proc Natl Acad Sci U S A 101 2004 1840 1845
111. L. Offertaler, F.M. Mo, S. Batkai, J. Liu, M. Begg, and R.K. Razdan Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor Mol Pharmacol 63 2003 699 705
112. Y. Okamoto, J. Morishita, K. Tsuboi, T. Tonai, and N. Ueda Molecular characterization of a phospholipase D generating anandamide and its congeners J Biol Chem 279 2004 5298 5305
113. G. Ortar, A. Ligresti, L. De Petrocellis, E. Morera, and V. Di Marzo Novel selective and metabolically stable inhibitors of anandamide cellular uptake Biochem Pharmacol 65 2003 1473 1481
114. S. Ortega-Gutierrez, E.G. Hawkins, A. Viso, M.L. Lopez-Rodriguez, and B.F. Cravatt Comparison of anandamide transport in faah wild-type and knockout neurons: evidence for contributions by both faah and the CB1 receptor to anandamide uptake Biochemistry 43 2004 8184 8190
115. S.E. O'Sullivan, D.A. Kendall, and M.D. Randall Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA) Br J Pharmacol 141 2004 803 812
116. M.P. Patricelli, and B.F. Cravatt Clarifying the catalytic roles of conserved residues in the amidase signature family J Biol Chem 275 2000 19177 19184
117. R.G. Pertwee Novel pharmacological targets for cannabinoids Curr Neuropharmacol 2 2004 9 29
118. G. Petersen, and H.S. Hansen N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability To transphosphatidylate FEBS Lett 455 1999 41 44
119. L. Pinto, A.A. Izzo, M.G. Cascio, T. Bisogno, K. Hospodar-Scott, and D.R. Brown Endocannabinoids as physiological regulators of colonic propulsion in mice Gastroenterology 123 2002 227 234
120. D. Piomelli, M. Beltramo, S. Glasnapp, S.Y. Lin, A. Goutopoulos, and X.Q. Xie Structural determinants for recognition and translocation by the anandamide transporter Proc Natl Acad Sci U S A 96 1999 5802 5807
121. A.C. Porter, J.M. Sauer, M.D. Knierman, G.W. Becker, M.J. Berna, and J. Bao Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 2002 1020 1024
122. L.S. Premkumar, and G.P. Ahern Induction of vanilloid receptor channel activity by protein kinase C Nature 408 2000 985 990
123. L.S. Premkumar, Z.H. Qi, J. Van Buren, and M. Raisinghani Enhancement of potency and efficacy of nada by PKC-mediated phosphorylation of vanilloid receptor J Neurophysiol 91 2004 1442 1449
124. R.A. Puffenbarger, O. Kapulina, J.M. Howell, and D.G. Deutsch Characterization of the 5′-sequence of the mouse fatty acid amide hydrolase Neurosci Lett 314 2001 21 24
125. R.A. Ross, T.M. Gibson, H.C. Brockie, M. Leslie, G. Pashmi, and S.J. Craib Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens Br J Pharmacol 132 2001 631 640
126. R.A. Ross, S.J. Craib, L.A. Stevenson, R.G. Pertwee, A. Henderson, and J. Toole Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide J Pharmacol Exp Ther 301 2002 900 907
127. L. Ruiz-Llorente, S. Ortega-Gutierrez, A. Viso, M.G. Sanchez, A.M. Sanchez, and C. Fernandez Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study Br J Pharmacol 141 2004 457 467
128. S. Sagan, L. Venance, Y. Torrens, J. Cordier, J. Glowinski, and C. Giaume Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes Eur J Neurosci 11 1999 691 699
129. H.H. Schmid, and E.V. Berdyshev Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function Prostaglandins Leukot Essent Fatty Acids 66 2002 363 376
130. P.C. Schmid, P.V. Reddy, V. Natarajan, and H.H. Schmid Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type J Biol Chem 258 1983 9302 9306
131. H.H. Schmid, P.C. Schmid, and V. Natarajan N-acylated glycerophospholipids and their derivatives Prog Lipid Res 29 1990 1 43
132. H.H. Schmid, P.C. Schmid, and V. Natarajan The N-acylation- phosphodiesterase pathway and cell signalling Chem Phys Lipids 80 1996 133 142
133. D. Smart, K.O. Jonsson, S. Vandevoorde, D.M. Lambert, and C.J. Fowler 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism Br J Pharmacol 136 2002 452 458
134. N. Stella, and D. Piomelli Receptor-dependent formation of endogenous cannabinoids in cortical neurons Eur J Pharmacol 425 2001 189 196
135. N. Stella, P. Schweitzer, and D. Piomelli A second endogenous cannabinoid that modulates long-term potentiation Nature 388 1997 773 778
136. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, and K. Itoh 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 1995 89 97
137. T. Sugiura, T. Kodaka, S. Nakane, S. Kishimoto, S. Kondo, and K. Waku Detection of an Endogenous cannabimimetic molecule, 2-arachidonoylglycerolz, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2- arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 243 1998 838 843
138. T. Sugiura, N. Yoshinaga, and K. Waku Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation Neurosci Lett 297 2001 175 178
139. T. Sugiura, Y. Kobayashi, S. Oka, and K. Waku Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance Prostaglandins Leukot Essent Fatty Acids 66 2002 173 192
140. Y.X. Sun, K. Tsuboi, Y. Okamoto, T. Tonai, M. Murakami, and I. Kudo Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A 2 and lysophospholipase D Biochem J 380 2004 749 756
141. J. Szolcsanyi Are cannabinoids endogenous ligands for the VR1 capsaicin receptor? Trends Pharmacol Sci 21 2000 41 42
142. G. Tarzia, A. Duranti, A. Tontini, G. Piersanti, M. Mor, and S. Rivara Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors J Med Chem 46 2003 2352 2360
143. N. Ueda, Q. Liu, and K. Yamanaka Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations Biochim Biophys Acta 1532 2001 121 127
144. N. Ueda, K. Yamanaka, and S. Yamamoto Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance J Biol Chem 276 2001 35552 35557
145. M. van der Stelt, J.A. van Kuik, M. Bari, G. van Zadelhoff, B.R. Leeflang, and G.A. Veldink Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase J Med Chem 45 2002 3709 3720
146. Z. Vogel, J. Barg, R. Levy, D. Saya, E. Heldman, and R. Mechoulam Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase J Neurochem 61 1993 352 355
147. N.S. Waleh, B.F. Cravatt, A. Apte-Deshpande, A. Terao, and T.S. Kilduff Transcriptional regulation of the mouse fatty acid amide hydrolase gene Gene 291 2002 203 210
148. L. Walter, and N. Stella Endothelin-1 increases 2-arachidonoyl glycerol (2-AG) production in astrocytes Glia 44 2003 85 90
149. L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, and G. Kunos Nonpsychotropic cannabinoid receptors regulate microglial cell migration J Neurosci 23 2003 1398 1405
150. E.J. Williams, F.S. Walsh, and P. Doherty The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response J Cell Biol 160 2003 481 486
151. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
152. D.F. Woodward, A.H. Krauss, J. Chen, R.K. Lai RK, C.S. Spada, and R.M. Burk The pharmacology of bimatoprost (Lumigan) Surv Ophthalmol 45 2001 S337 S345
153. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgard, and V. Di Marzo Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457
154. P.M. Zygmunt, H. Chuang, P. Movahed, D. Julius, and E.D. Hogestatt The anandamide transport inhibitor AM404 activates vanilloid receptors Eur J Pharmacol 396 2000 39 42